Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of reduced neutralization of the VOCs B.1.1.7 and B.1.351 by vaccine sera in laboratory assays. We performed a matched cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kustin, Talia, Harel, Noam, Finkel, Uriah, Perchik, Shay, Harari, Sheri, Tahor, Maayan, Caspi, Itamar, Levy, Rachel, Leshchinsky, Michael, Ken Dror, Shifra, Bergerzon, Galit, Gadban, Hala, Gadban, Faten, Eliassian, Eti, Shimron, Orit, Saleh, Loulou, Ben-Zvi, Haim, Keren Taraday, Elena, Amichay, Doron, Ben-Dor, Anat, Sagas, Dana, Strauss, Merav, Shemer Avni, Yonat, Huppert, Amit, Kepten, Eldad, Balicer, Ran D., Netzer, Doron, Ben-Shachar, Shay, Stern, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363499/
https://www.ncbi.nlm.nih.gov/pubmed/34127854
http://dx.doi.org/10.1038/s41591-021-01413-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363499/
https://www.ncbi.nlm.nih.gov/pubmed/34127854
http://dx.doi.org/10.1038/s41591-021-01413-7

Ejemplares similares